Articles published by Arcturus Therapeutics Holdings Inc.
![](https://mms.businesswire.com/media/20230307005396/en/837248/5/arcturus-logo-blueback.jpg)
![](https://mms.businesswire.com/media/20230206005220/en/837248/5/arcturus-logo-blueback.jpg)
Arcturus Therapeutics to Attend Upcoming Investor Conferences
February 06, 2023
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20230131005546/en/1700583/5/arcturus-logo-blueback_%282%29.jpg)
![](https://mms.businesswire.com/media/20221219005237/en/837248/5/arcturus-logo-blueback.jpg)
Arcturus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 19, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20221213005428/en/1663063/5/Markels_Headshot.jpg)
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
December 13, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20221109006003/en/1631830/4/update_graphic_-_11.1.jpg)
Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress
November 09, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20221107006097/en/837248/5/arcturus-logo-blueback.jpg)
Arcturus Therapeutics to Present at the Following Investor Conferences in November
November 07, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20221101006199/en/837248/5/arcturus-logo-blueback.jpg)
Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
November 01, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20221026005361/en/837248/5/arcturus-logo-blueback.jpg)
![](https://mms.businesswire.com/media/20220927006121/en/837248/5/arcturus-logo-blueback.jpg)
Arcturus Therapeutics to Attend the Following Investor Conferences
September 27, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20220901005815/en/837248/5/arcturus-logo-blueback.jpg)
Arcturus Therapeutics to Attend the Following Investor Conferences
September 01, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20220831005234/en/837248/5/arcturus-logo-blueback.jpg)
![](https://mms.businesswire.com/media/20220818005266/en/1547667/5/Omicron_181_2Fig_V4.jpg)
![](https://mms.businesswire.com/media/20220809006007/en/1538566/5/BA.1%2C_BA.2_graphic.jpg)
Arcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline Progress
August 09, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20220801005045/en/837248/5/arcturus-logo-blueback.jpg)
![](https://mms.businesswire.com/media/20220621005189/en/1490754/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20220520005478/en/1463244/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
![](https://mms.businesswire.com/media/20220509006091/en/1448598/5/20220505_Omicrons_MNT.jpg)
![](https://mms.businesswire.com/media/20220505005501/en/1444825/5/Figure_2_20220503_sVNT_154_PR.jpg)
![](https://mms.businesswire.com/media/20220422005640/en/1430370/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20220420005466/en/1426181/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
![](https://mms.businesswire.com/media/20220325005100/en/1400803/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
![](https://mms.businesswire.com/media/20220318005432/en/1394944/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20220314005321/en/1388339/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20220218005546/en/1365318/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 18, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20220207006010/en/1352514/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
Arcturus Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
February 08, 2022
Via Business Wire
Tickers
ARCT
![](https://mms.businesswire.com/media/20220125005602/en/1337890/5/20220125_ARCT_PR_Omicron_data_image_FINAL.jpg)
![](https://mms.businesswire.com/media/20220124005288/en/1336230/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
![](https://mms.businesswire.com/media/20211217005661/en/1310845/5/ARCT_LOGO_arcturus-logo-blueback.jpg)
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 17, 2021
Via Business Wire
Tickers
ARCT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.